Related Experiment Video
Updated: Jun 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Four novel ATP2A2 mutations in Slovenian patients with Darier disease
Aleksandar Godic1, Branka Korosec, Jovan Miljković
1Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. aleksandar.godic@gmail.com
Background:
Darier disease (DD) is an autosomal dominant genodermatosis caused by mutations in the ATP2A2 gene. It has been reported that depletion of Ca(2+) stores within the endoplasmic reticulum of keratinocytes is associated with impaired cell cycle regulation and terminal differentiation. Mechanical stress, heat, or UV irradiation might delay cell cycle exit and permit progression into the quiescent stage without repair. When there is associated DNA damage, this can lead to an accumulation of secondary somatic mutations and possible clonal proliferation of damaged keratinocyes within keratotic papules and plaques.
Objective:
We sought to present clinical, demographic, and genetic analysis of the cohort of Slovenian patients with DD, which represents 52% of DD patients in the country.
Methods:
We examined 28 Slovenians with DD and screened genomic DNA for ATP2A2 mutations and RNA for splice site mutations.
Results:
The estimated prevalence of the disease in Slovenia is 2.7/100.000. We identified 7 different ATP2A2 mutations, 4 of which are novel: A516P, R559G, 463-6del6, and 1762-6del18. We also found two previously described polymorphisms in intron XVIII (2741 + 54 G>A) and in exon 15 (2172 G>A; A724A), with allele frequencies of 64.15% and 11.32%, respectively. There was a history of perceptive deafness in two DD patients from two families.
Limitations:
Analysis of SERCA2 expression, measurements of Ca(2+) uptake and their influence on desmosomal assembly in vitro would add additional value to the study. Although single-stranded conformational analysis (SSCP) is a common and accepted method for screening for the presence of mutations, it does miss 10% to 20% of mutations.
Conclusions:
We identified 4 novel ATP2A2 mutations in Slovenian patients with DD. Deafness seems to be a new phenotypic characteristic of DD patients.
Insights
Darier disease (DD) is a genetic skin disorder caused by ATP2A2 gene mutations. This study identified four novel mutations in Slovenian patients and suggests deafness may be a new characteristic of DD.
Area of Science:
- Genetics
- Dermatology
- Molecular Biology
Background:
- Darier disease (DD) is an autosomal dominant genodermatosis linked to ATP2A2 gene mutations.
- Keratinocyte calcium (Ca2+) store depletion impacts cell cycle regulation and differentiation.
- Accumulated DNA damage and secondary mutations can lead to clonal proliferation in DD lesions.
Purpose of the Study:
- To conduct a clinical, demographic, and genetic analysis of Slovenian Darier disease patients.
- To characterize the ATP2A2 mutations present in the Slovenian DD cohort.
- To investigate potential new phenotypic features associated with DD.
Main Methods:
- Examined 28 Slovenian patients diagnosed with Darier disease.
- Screened genomic DNA for ATP2A2 gene mutations.
- Analyzed RNA for splice site mutations.
Main Results:
- Estimated Darier disease prevalence in Slovenia at 2.7/100,000.
- Identified 7 distinct ATP2A2 mutations, including 4 novel ones (A516P, R559G, 463-6del6, 1762-6del18).
- Observed a history of perceptive deafness in two families with DD, suggesting a potential new phenotype.
Conclusions:
- Four novel ATP2A2 mutations were identified in Slovenian Darier disease patients.
- Deafness appears to be a newly recognized phenotypic characteristic associated with Darier disease.
- Further in vitro studies on SERCA2 expression and Ca2+ uptake are recommended to understand desmosomal assembly in DD.
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
Lysosomal Hydrolases
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Animal Mitochondrial Genetics
The ADP/ATP Carrier Protein
